ACADIA Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020
January 07 2020 - 9:00AM
Business Wire
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical
company focused on the development and commercialization of
innovative medicines that address unmet medical needs in central
nervous system disorders, today announced that it will present at
the 38th Annual J.P. Morgan Healthcare Conference in San Francisco
on Tuesday, January 14, 2020, at 10:00 a.m. Pacific Time, followed
by a question and answer breakout session.
A live webcast of ACADIA’s presentation and breakout session
will be accessible on the company’s website, www.acadia-pharm.com,
under the investors section and an archived recording will be
available on the website through February 14, 2020.
About ACADIA Pharmaceuticals
ACADIA is a biopharmaceutical company focused on the development
and commercialization of innovative medicines to address unmet
medical needs in central nervous system disorders. ACADIA has
developed and commercialized the first and only medicine approved
for the treatment of hallucinations and delusions associated with
Parkinson’s disease psychosis. ACADIA also has ongoing clinical
development efforts in additional areas with significant unmet
need, including dementia-related psychosis, major depressive
disorder, the negative symptoms of schizophrenia, and Rett
syndrome. This press release and further information about ACADIA
can be found at: www.acadia-pharm.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200107005288/en/
Media Contact:ACADIA Pharmaceuticals Inc.Stephanie Fagan(858)
212-0534media@acadia-pharm.com
Investor Contact:ACADIA Pharmaceuticals Inc.Mark Johnson,
CFA(858) 261-2771ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2023 to Apr 2024